Levonorgestrel plasma levels in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system (Mirena)

被引：0
|
作者：
Gschliesser, A. [1 ,2 ]
Seeber, B. [2 ]
Moser, C. [3 ]
Seger, C. [3 ]
Mattle, V. [2 ]
Concin, H. [4 ]
Wildt, L. [2 ]
机构：
[1] Innsbruck Med Univ, Dept Gynecol & Obstet, Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Gynecol Endocrinol & Reprod Med, Innsbruck, Austria
[3] Univ Innsbruck Hosp, Div Mass Spectrometry & Chromatog, Inst Med & Chem Lab, Diagnost ZIMCL, A-6020 Innsbruck, Austria
[4] Landeskrankenhaus Bregenz, Dept Obstet & Gynecol, Bregenz, Austria
来源：
HUMAN REPRODUCTION | 2011年 / 26卷
关键词：
D O I：
10.1093/humrep/26.s1.83
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：I246 / I247
页数：2
相关论文
共 50 条
  • [1] Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system
    Seeber, Beata
    Ziehr, Stephanie C.
    Gschliesser, Aandrea
    Moser, Christina
    Mattle, Verena
    Seger, Christoph
    Griesmacher, Andrea
    Concin, Nicole
    Concin, Hans
    Wildt, Ludwig
    [J]. CONTRACEPTION, 2012, 86 (04) : 345 - 349
  • [2] Mirena - Levonorgestrel-releasing intrauterine system
    不详
    [J]. FORMULARY, 2001, 36 (02) : 93 - 93
  • [3] Levonorgestrel-releasing intrauterine system (Mirena) for contraception
    McCarthy, Lisa
    [J]. AMERICAN FAMILY PHYSICIAN, 2006, 73 (10) : 1799 - 1801
  • [4] Quantitative levonorgestrel plasma level measurements in patients with regular and prolonged use of the levonorgestrel-releasing intrauterine system (vol 86, pg 345, 2012)
    Seeber, Beata
    Ziehr, Stephanie C.
    Gschliesser, Andreas
    Moser, Christina
    Mattle, Verena
    Seger, Christoph
    Griesmacher, Andrea
    Concin, Nicole
    Concin, Hans
    Wildt, Ludwig
    [J]. CONTRACEPTION, 2013, 88 (01) : 194 - 194
  • [5] Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena®)
    Ndumbe, FM
    Husemeyer, RP
    [J]. JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2006, 32 (02): : 113 - 114
  • [6] Levonorgestrel-releasing intrauterine system (Mirena®) as a therapy for endometrial hyperplasia and carcinoma
    Bahamondes, L
    Ribeiro-Huguet, P
    de Andrade, KC
    Leon-Martins, O
    Petta, CA
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2003, 82 (06) : 580 - 582
  • [7] Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena®) in Campinas, Brazil
    Diaz, J
    Bahamondes, L
    Monteiro, I
    Petta, C
    Hildalgo, MM
    Arce, XE
    [J]. CONTRACEPTION, 2000, 62 (02) : 59 - 61
  • [8] Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system
    Hidalgo, Maria M.
    Hidalgo-Regina, Creusa
    Bahamondes, M. Valeria
    Monteiro, Ilza
    Petta, Carlos A.
    Bahamondes, Luis
    [J]. CONTRACEPTION, 2009, 80 (01) : 84 - 89
  • [9] Use of the levonorgestrel-releasing intrauterine system in breast cancer patients
    Trinh, Xuan Bich
    Tjalma, Wiebren A. A.
    Makar, Amin P.
    Buytaert, Guy
    Weyler, Joost
    van Dam, Peter A.
    [J]. FERTILITY AND STERILITY, 2008, 90 (01) : 17 - 22
  • [10] The levonorgestrel-releasing intrauterine system for menorrhagia
    Lewis, P
    Selvakumari, NK
    Neelapalla, S
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (01): : 46 - 46
12345